Karyopharm Therapeutics Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2018 | — | -593.0% | -588.1% |
| FY2019 | — | -462.9% | -488.1% |
| FY2020 | — | -159.0% | -181.6% |
| FY2021 | — | -46.8% | -59.1% |
| FY2022 | — | -90.5% | -105.2% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2018 | — | -593.0% | -588.1% |
| FY2019 | — | -462.9% | -488.1% |
| FY2020 | — | -159.0% | -181.6% |
| FY2021 | — | -46.8% | -59.1% |
| FY2022 | — | -90.5% | -105.2% |